Davis Stephen
- SEC CIK
- 0001131146
No open-market purchases or sales filed in the past year.
Current role at each company
- ACAD Acadia Pharmaceuticals IncCEOas of Aug 20, 2024
- Bellicum Pharmaceuticals, IncDirectoras of Jan 5, 2023
- HRTX Heron Therapeutics, Inc.Directoras of Dec 20, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Davis Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACAD Acadia Pharmaceuticals Inc
CEO18 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Davis StephenCEO | SSale | −31.7K | $15.28 | −$485.1K | −14.5%186.6K after | |
| May 3, 2024 (view filing) | May 2 | 1 day | Davis StephenCEO | SSale | −11.4K | $16.94 | −$193.6K | −6.9%155.2K after | |
| Apr 9, 2024 (view filing) | Apr 8 | 1 day | Davis StephenCEO | SSale | −26.6K | $17.87 | −$474.9K | −15.6%144.3K after | 2 lots |
| Mar 27, 2024 (view filing) | Mar 27 | Same day | Davis StephenCEO | SSale | −17.7K | $17.90 | −$317.1K | −13.0%118.8K after | |
| Feb 27, 2024 (view filing) | Feb 26 | 1 day | Davis StephenCEO | SSale | −5.58K | $24.67 | −$137.6K | −5.2%101.9K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Davis StephenCEO | SSale | −3.73K | $29.96 | −$111.8K | −3.7%96.5K after | |
| Oct 6, 2023 (view filing) | Oct 6 | Same day | Davis StephenCEO | SSale | −51.6K | $21.96 | −$1.13M | −36.6%89.1K after | |
| Jul 18, 2023 (view filing) | Jul 14 | 4 days | Davis StephenCEO | SSale | −100.0K | $30.04 | −$3.00M | −73.2%36.7K after | 10b5-1 |
| Jul 13, 2023 (view filing) | Jul 11-12 | 2 days | Davis StephenCEO | SSale | −71.6K | $25.04 | −$1.79M | −66.1%36.7K after | 2 lots10b5-1 |
| May 2, 2023 (view filing) | May 1 | 1 day | Davis StephenCEO | SSale | −7.81K | $21.18 | −$165.3K | −6.7%108.3K after |